| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Usage # |
|---|
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-InsurancePlan.period.json | R4: When the product is available (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-InsurancePlan.plan.json | R4: Plan details (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-InsurancePlan.status.json | R4: draft | active | retired | unknown (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-InsurancePlan.type.json | R4: Kind of product (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Invoice.account.json | R4: Account that is being balanced (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Invoice.cancelledReason.json | R4: Reason for cancellation of this Invoice (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Invoice.date.json | R4: Invoice date / posting date (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Invoice.issuer.json | R4: Issuing Organization of Invoice (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Invoice.lin.pri.amount.json | R4: Monetary amount associated with this component (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Invoice.lin.pri.code.json | R4: Code identifying the specific component (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Invoice.lin.pri.factor.json | R4: Factor used for calculating this component (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Invoice.lin.pri.type.json | R4: base | surcharge | deduction | discount | tax | informational (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Invoice.lin.priceComponent.json | R4: priceComponent | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Invoice.lineItem.json | R4: Line items of this Invoice (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Invoice.note.json | R4: Comments made about the invoice (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Invoice.participant.json | R4: Participant in creation of this Invoice (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Invoice.paymentTerms.json | R4: Payment details (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Invoice.recipient.json | R4: Recipient of this invoice (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Invoice.status.json | R4: draft | issued | balanced | cancelled | entered-in-error (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Invoice.totalGross.json | R4: Gross total of this Invoice (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Invoice.totalNet.json | R4: Net total of this Invoice (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Invoice.type.json | R4: Type of Invoice (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Library.author.json | R4: Who authored the content additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Library.editor.json | R4: Who edited the content additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Library.endorser.json | R4: Who endorsed the content additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Library.reviewer.json | R4: Who reviewed the content additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Library.subject.json | R4: Type of individual the library content is focused on (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Library.subtitle.json | R4: Subordinate title of the library (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Location.availabilityExceptions.json | R4: Description of availability exceptions (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Location.hou.allDay.json | R4: The Location is open all day additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Location.hou.closingTime.json | R4: Time that the Location closes (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Location.hou.daysOfWeek.json | R4: mon | tue | wed | thu | fri | sat | sun additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Location.hou.openingTime.json | R4: Time that the Location opens (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Location.hoursOfOperation.json | R4: What days/times during a week is this location usually open (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Location.telecom.json | R4: Contact details of the location (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MarketingStatus.country.json | R4: The country in which the marketing authorisation has been granted shall be specified It should be specified using the ISO 3166 ‑ 1 alpha-2 code elements (new) | trial-use | 0 | fhir | 2026-03 | |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MarketingStatus.dateRange.json | R4: The date when the Medicinal Product is placed on the market by the Marketing Authorisation Holder (or where applicable, the manufacturer/distributor) in a country and/or jurisdiction shall be provided A complete date consisting of day, month and year shall be specified using the ISO 8601 date format NOTE “Placed on the market” refers to the release of the Medicinal Product into the distribution chain (new) | trial-use | 0 | fhir | 2026-03 | |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MarketingStatus.jurisdiction.json | R4: Where a Medicines Regulatory Agency has granted a marketing authorisation for which specific provisions within a jurisdiction apply, the jurisdiction can be specified using an appropriate controlled terminology The controlled term and the controlled term identifier shall be specified (new) | trial-use | 0 | fhir | 2026-03 | |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MarketingStatus.restoreDate.json | R4: The date when the Medicinal Product is placed on the market by the Marketing Authorisation Holder (or where applicable, the manufacturer/distributor) in a country and/or jurisdiction shall be provided A complete date consisting of day, month and year shall be specified using the ISO 8601 date format NOTE “Placed on the market” refers to the release of the Medicinal Product into the distribution chain (new) | trial-use | 0 | fhir | 2026-03 | |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MarketingStatus.status.json | R4: This attribute provides information on the status of the marketing of the medicinal product See ISO/TS 20443 for more information and examples (new) | trial-use | 0 | fhir | 2026-03 | |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Measure.author.json | R4: Who authored the content additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Measure.editor.json | R4: Who edited the content additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Measure.endorser.json | R4: Who endorsed the content additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Measure.gro.code.json | R4: Meaning of the group additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Measure.gro.str.code.json | R4: Meaning of the stratifier additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Measure.gro.str.component.json | R4: Stratifier criteria component for the measure (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Measure.gro.str.description.json | R4: The human readable description of this stratifier (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Measure.improvementNotation.json | R4: increase | decrease additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Measure.library.json | R4: library additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Measure.reviewer.json | R4: Who reviewed the content additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Measure.subject.json | R4: E.g. Patient, Practitioner, RelatedPerson, Organization, Location, Device (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Measure.subtitle.json | R4: Subordinate title of the measure (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Measure.sup.code.json | R4: Meaning of the supplemental data additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Measure.sup.description.json | R4: The human readable description of this supplemental data (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MeasureReport.gro.code.json | R4: Meaning of the group additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MeasureReport.gro.measureScore.json | R4: measureScore additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MeasureReport.gro.str.code.json | R4: code additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MeasureReport.gro.str.str.component.json | R4: Stratifier component values (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MeasureReport.gro.str.str.measureScore.json | R4: measureScore additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MeasureReport.gro.str.str.value.json | R4: value additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MeasureReport.improvementNotation.json | R4: increase | decrease (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MeasureReport.measure.json | R4: What measure was calculated additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MeasureReport.type.json | R4: individual | subject-list | summary | data-collection | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Media.created.json | R4: When Media was collected (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Media.deviceName.json | R4: Name of the device/manufacturer (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Media.device.json | R4: Observing Device (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Media.duration.json | R4: Length in seconds (audio / video) (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Media.encounter.json | R4: Encounter associated with media (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Media.frames.json | R4: Number of frames if > 1 (photo) (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Media.height.json | R4: Height of the image in pixels (photo/video) (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Media.issued.json | R4: Date/Time this version was made available (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Media.note.json | R4: Comments made about the media (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Media.operator.json | R4: The person who generated the image (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Media.partOf.json | R4: Part of referenced event (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Media.reasonCode.json | R4: Why was event performed? (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Media.status.json | R4: preparation | in-progress | not-done | on-hold | stopped | completed | entered-in-error | unknown (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Media.type.json | R4: Classification of media as image, video, or audio additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Media.view.json | R4: Imaging view, e.g. Lateral or Antero-posterior (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Media.width.json | R4: Width of the image in pixels (photo/video) (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Medication.amount.json | R4: Amount of drug in package (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Medication.batch.json | R4: Details about packaged medications (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-Medication.identifier.json | R4: Business identifier for this medication (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-Medication.ing.item.json | R4: The actual ingredient or content additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationAdministration.effective.json | R4: Start and end time of administration (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationAdministration.instantiates.json | R4: Instantiates protocol or definition (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MA.per.actor.json | R4: Who performed the medication administration additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MA.per.function.json | R4: Type of performance (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationAdministration.reasonReference.json | R4: Condition or observation that supports why the medication was administered additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationAdministration.statusReason.json | R4: Reason administration not performed (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationAdministration.status.json | R4: in-progress | not-done | on-hold | completed | entered-in-error | stopped | unknown additional codes | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationDispense.detectedIssue.json | R4: Clinical issue with action (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationDispense.per.function.json | R4: Who performed the dispense and what they did (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationDispense.statusReason.json | R4: Why a dispense was not performed (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationDispense.status.json | R4: preparation | in-progress | cancelled | on-hold | completed | entered-in-error | stopped | declined | unknown additional codes | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.adm.indication.json | R4: Indication for use that apply to the specific administration guidelines (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.adm.pat.characteristic.json | R4: Specific characteristic that is relevant to the administration guideline (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.adm.pat.value.json | R4: The specific characteristic (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.administrationGuidelines.json | R4: Guidelines for administration of the medication (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.amount.json | R4: Amount of drug in package (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.associatedMedication.json | R4: A medication resource that is associated with this medication (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.code.json | R4: Code that identifies this medication (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.contraindication.json | R4: Potential clinical issue with or between medication(s) (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.cost.json | R4: The pricing of the medication (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.doseForm.json | R4: powder | tablets | capsule + (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.dru.value.json | R4: Description of the characteristic (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.drugCharacteristic.json | R4: Specifies descriptive properties of the medicine (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.ingredient.json | R4: Active or inactive ingredient (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.intendedRoute.json | R4: The intended or approved route of administration (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.kinetics.json | R4: The time course of drug absorption, distribution, metabolism and excretion of a medication from the body (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.manufacturer.json | R4: Manufacturer of the item (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.medicineClassification.json | R4: Categorization of the medication within a formulary or classification system (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.monitoringProgram.json | R4: Program under which a medication is reviewed (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.monograph.json | R4: Associated documentation about the medication (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.pac.quantity.json | R4: The number of product units the package would contain if fully loaded (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.pac.type.json | R4: A code that defines the specific type of packaging that the medication can be found in (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.packaging.json | R4: Details about packaged medications (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.preparationInstruction.json | R4: The instructions for preparing the medication (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.productType.json | R4: Category of the medication or product (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.reg.sch.schedule.json | R4: Specifies the specific drug schedule (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.regulatory.json | R4: Regulatory information about a medication (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.rMK.json | R4: Associated or related medication information (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.synonym.json | R4: Additional names for a medication (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.courseOfTherapyType.json | R4: Overall pattern of medication administration (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.detectedIssue.json | R4: Clinical Issue with action (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.dis.dispenseInterval.json | R4: Minimum period of time between dispenses (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.dis.initialFill.json | R4: First fill details (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.dis.nORA.json | R4: numberOfRepeatsAllowed additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.doNotPerform.json | R4: True if request is prohibiting action (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.instantiatesCanonical.json | R4: Instantiates FHIR protocol or definition (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.instantiatesUri.json | R4: Instantiates external protocol or definition (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.insurance.json | R4: Associated insurance coverage (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.intent.json | R4: proposal | plan | order | original-order | reflex-order | filler-order | instance-order | option | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.performerType.json | R4: Desired kind of performer of the medication administration (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.performer.json | R4: Intended performer of administration (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.reasonReference.json | R4: Condition or observation that supports why the prescription is being written additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.reported.json | R4: Reported rather than primary record additional types | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.statusReason.json | R4: Reason for current status (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.status.json | R4: active | on-hold | cancelled | completed | entered-in-error | stopped | draft | unknown additional codes | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.sub.allowed.json | R4: Whether substitution is allowed or not additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationStatement.reasonCode.json | R4: Reason for why the medication is being/was taken (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationStatement.reasonReference.json | R4: Condition or observation that supports why the medication is being/was taken (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationStatement.statusReason.json | R4: Reason for current status (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r5 | R5 | StructureDefinition/StructureDefinition-ext-R4-MedicationStatement.status.json | R4: active | completed | entered-in-error | intended | stopped | on-hold | unknown | not-taken | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.aMI.json | R4: Whether the Medicinal Product is subject to additional monitoring for regulatory reasons (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.attachedDocument.json | R4: Supporting documentation, typically for regulatory submission (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.clinicalTrial.json | R4: Clinical trials or studies that this product is involved in (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.cPDF.json | R4: The dose form for a single part product, or combined form of a multiple part product (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.contact.json | R4: A product specific contact, person (in a role), or an organization (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.crossReference.json | R4: Reference to another product, e.g. for linking authorised to investigational product (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.domain.json | R4: If this medicine applies to human or veterinary uses (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.legalStatusOfSupply.json | R4: The legal status of supply of the medicinal product as classified by the regulator (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.mBO.json | R4: An operation applied to the product, for manufacturing or adminsitrative purpose (new) | trial-use | 0 | fhir | 2026-03 | 5 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.marketingStatus.json | R4: Marketing status of the medicinal product, in contrast to marketing authorizaton (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.masterFile.json | R4: A master file for to the medicinal product (e.g. Pharmacovigilance System Master File) (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.name.json | R4: The product's name, including full name and possibly coded parts (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.packagedMedicinalProduct.json | R4: Package representation for the product additional types | trial-use | 0 | fhir | 2026-03 | 5 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.paediatricUseIndicator.json | R4: If authorised for use in children (new) | trial-use | 0 | fhir | 2026-03 | 5 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.pharmaceuticalProduct.json | R4: Pharmaceutical aspects of product (new) | trial-use | 0 | fhir | 2026-03 | 5 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.productClassification.json | R4: Allows the product to be classified by various systems (new) | trial-use | 0 | fhir | 2026-03 | 5 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.specialDesignation.json | R4: Indicates if the medicinal product has an orphan designation for the treatment of a rare disease (new) | trial-use | 0 | fhir | 2026-03 | 5 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.specialMeasures.json | R4: specialMeasures additional types | trial-use | 0 | fhir | 2026-03 | 5 |
| hl7.fhir.uv.xver-r4.r3 | R3 | StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.type.json | R4: Regulatory type, e.g. Investigational or Authorized (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.country.json | R4: The country in which the marketing authorization has been granted (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MPA.dEP.json | R4: A period of time after authorization before generic product applicatiosn can be submitted (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MPA.dOFA.json | R4: The date when the first authorization was granted by a Medicines Regulatory Agency (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.holder.json | R4: Marketing Authorization Holder (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MPA.iBD.json | R4: Date of first marketing authorization for a company's new medicinal product in any country in the World (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.jurisdiction.json | R4: Jurisdiction within a country (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MPA.jA.json | R4: Authorization in areas within a country (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.legalBasis.json | R4: The legal framework against which this authorization is granted (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.procedure.json | R4: The regulatory procedure for granting or amending a marketing authorization (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.regulator.json | R4: Medicines Regulatory Agency (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.restoreDate.json | R4: The date when a suspended the marketing or the marketing authorization of the product is anticipated to be restored (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.statusDate.json | R4: The date at which the given status has become applicable (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.status.json | R4: The status of the marketing authorization (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.validityPeriod.json | R4: The beginning of the time period in which the marketing authorization is in the specific status shall be specified A complete date consisting of day, month and year shall be specified using the ISO 8601 date format (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductContraindication.comorbidity.json | R4: A comorbidity (concurrent condition) or coinfection (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MPC.diseaseStatus.json | R4: The status of the disease or symptom for the contraindication (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductContraindication.disease.json | R4: The disease, symptom or procedure for the contraindication (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductContraindication.otherTherapy.json | R4: Information about the use of the medicinal product in relation to other therapies described as part of the indication (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductContraindication.population.json | R4: The population group to which this applies (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MPC.tI.json | R4: Information about the use of the medicinal product in relation to other therapies as part of the indication (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductIndication.comorbidity.json | R4: Comorbidity (concurrent condition) or co-infection as part of the indication (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductIndication.diseaseStatus.json | R4: The status of the disease or symptom for which the indication applies (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MPI.dSP.json | R4: The disease, symptom or procedure that is the indication for treatment (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductIndication.duration.json | R4: Timing or duration information as part of the indication (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductIndication.intendedEffect.json | R4: The intended effect, aim or strategy to be achieved by the indication (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductIndication.otherTherapy.json | R4: Information about the use of the medicinal product in relation to other therapies described as part of the indication (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductIndication.population.json | R4: The population group to which this applies (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductIndication.undesirableEffect.json | R4: Describe the undesirable effects of the medicinal product (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MPI.allergenicIndicator.json | R4: If the ingredient is a known or suspected allergen (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductIngredient.manufacturer.json | R4: Manufacturer of this Ingredient (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductIngredient.role.json | R4: Ingredient role e.g. Active ingredient, excipient (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MPI.spe.strength.json | R4: Quantity of the substance or specified substance present in the manufactured item or pharmaceutical product (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductIngredient.specifiedSubstance.json | R4: A specified substance that comprises this ingredient (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductIngredient.substance.json | R4: The ingredient substance (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductInteraction.description.json | R4: The interaction described (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductInteraction.effect.json | R4: The effect of the interaction, for example "reduced gastric absorption of primary medication" (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductInteraction.incidence.json | R4: The incidence of the interaction, e.g. theoretical, observed (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition/StructureDefinition-ext-R4-MedicinalProductInteraction.interactant.json | R4: The specific medication, food or laboratory test that interacts (new) | trial-use | 0 | fhir | 2026-03 | 4 |
FHIR IG analytics
FHIR
FHIRsmith